Celgene CorpAdd to My Watchlist

CELG:USNASDAQ GSIndustry: Medical-Biomedical/Gene
  • 112.67
  • 0.93  -0.82%
    Today's Change
  • 113.60
    Previous Close
  • Today
    52 Week Low - High
8:10 pm ET 11/24/2015
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding786 million
Market Cap$89 billion
Return on Equity ttm29.70%
Last DividendCELG:US does not pay a dividend
EPS: Year Actual ttm2.276
EPS: Year Est. 12/15 ttm4.812
EPS: Quarterly Actual 9/15 1.23
EPS: Quarterly Est. 12/15 1.27
Price/Earnings ttm49.49
Relative Price/Earnings2.651
Earnings Growth Rate42.29
Company Description
Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.
Revenue$8 billion
Net Income$2 billion
Total Assets$17 billion
Web Sitewww.celgene.com

Latest Headlines


Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

Sign In Now


Not Registered?

Get complete access to The Washington Post online - it's FREE!